Position in HLN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,138,032
-$205,236 QoQ
Shares Held
443,519
+2.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#78
of 639 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 97%
Shared 2%
None 1%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Pinnacle Financial Partners, Inc. holds $11,711,215 across 6 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (35.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
78,827 | $5,664,506 | |
| 2 | HLN |
Haleon plc
This page
|
443,519 | $4,138,032 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,862 | $1,008,885 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
14,692 | $497,764 | |
| 5 | VTRS |
Viatris Inc
|
22,697 | $360,428 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
10,000 | $41,600 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,138,032 | 443,519 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $4,343,268 | 433,893 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,358,299 | 431,088 | Shares | Defined | 2026-02-18 | |
| No filing history on record for this holder in this stock. | ||||||